1. Positioning of proteasome inhibitors in therapy of solid malignancies
   Margot S. F. Roeten et al, 2017, Cancer Chemother Pharmacol CrossRef
2. Meloxicam combined with sorafenib synergistically inhibits tumor growth of human hepatocellular carcinoma cells via ER stress-related apoptosis
   JINGTAO ZHONG et al, 2015 CrossRef
3. A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus – clinical significance and possible mechanisms: a case report
   Nobuo Takemori et al, 2018, J Med Case Reports CrossRef
4. Designing an effective drug combination for ER stress loading in cancer therapy using a real-time monitoring system
   Hiromi Kazama et al, 2018, Biochemical and Biophysical Research Communications CrossRef
5. Azithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up-regulating the protein levels of DR4/5 in colon cancer cells in vitro and in vivo
   Xinran Qiao et al, 2018, Cancer Commun CrossRef
6. Potential therapeutic approaches for modulating expression and accumulation of defective lamin A in laminopathies and age-related diseases
   Alex Zhavoronkov et al, 2012, J Mol Med CrossRef
7. Macrolide antibiotics block autophagy flux and sensitize to bortezomib via endoplasmic reticulum stress-mediated CHOP induction in myeloma cells.
   Shota Moriya et al, 2013, Int. J. Oncol. CrossRef
8. Bortezomid enhances the efficacy of lidamycin against human multiple myeloma cells
   Yong-Zhan Zhen et al, 2013, Anti-Cancer Drugs CrossRef
9. Mechanisms of proteasome inhibitor-induced cytotoxicity in malignant glioma
   Panagiotis J. Vlachostergios et al, 2013, Cell Biol Toxicol CrossRef
10. Combined treatment with SAHA, bortezomib, and clarithromycin for concomitant targeting of aggresome formation and intracellular proteolytic pathways enhances ER stress-mediated cell death in breast cancer cells
    Seiichiro Komatsu et al, 2013, Biochemical and Biophysical Research Communications CrossRef
11. Downregulation of the miR-30 family microRNAs contributes to endoplasmic reticulum stress in cardiac muscle and vascular smooth muscle cells
    Ming Chen et al, 2014, International Journal of Cardiology CrossRef
12. Targeting the integrated networks of aggresome formation, proteasome, and autophagy potentiates ER stress‑mediated cell death in multiple myeloma cells.
    Shota Moriya et al, 2015, Int. J. Oncol. CrossRef
13. Fluorosis Induces Endoplasmic Reticulum Stress and Apoptosis in Osteoblasts In Vivo
    Lu Liu et al, 2015, Biol Trace Elem Res CrossRef
14. Different Roles of CHOP and JNK in Mediating Radiation-Induced Autophagy and Apoptosis in Breast Cancer Cells
    Feifei Li et al, 2016, Radiation Research CrossRef
15. Targeting bortezomib-induced aggresome formation using vinorelbine enhances the cytotoxic effect along with ER stress loading in breast cancer cell lines
    Kana Miyahara et al, 2016 CrossRef
16. In vitropotential cytogenetic and oxidative stress effects of roxithromycin
    Mehmet Arslan et al, 2017, Drug and Chemical Toxicology CrossRef
17. null
    Masahiro Itoh, 2017 CrossRef
18. Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo
    Bo Zhou et al, 2019, J Ovarian Res CrossRef
19. Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K
    Giulia Petroni et al, 2020, Cell Death Dis CrossRef
20. Clarithromycin effectively enhances doxorubicin-induced cytotoxicity and apoptosis in MCF7 cells through dysregulation of autophagy
    Nahid Amani et al, 2020, Advances in Medical Sciences CrossRef
21. miR-1271 inhibits ERα expression and confers letrozole resistance in breast cancer
    Tao Yu et al, 2017, Oncotarget CrossRef
22. Effect of uremic serum on Th17/Treg cell balance and endoplasmic reticulum stress in rats
    Dan Xiao et al, 2020, Biomedicine & Pharmacotherapy CrossRef
23. Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
    Christina Pfab et al, 2021, Cancers CrossRef
24. Induction of synergistic non‑apoptotic cell death by simultaneously targeting proteasomes with bortezomib and histone deacetylase 6 with ricolinostat in head and neck tumor cells
    Kazuhiro Hattori et al, 2021, Oncol Lett CrossRef
25. Proteasome inhibition induces macrophage apoptosis via mitochondrial dysfunction
    Jieyan Wang et al, 2021, J Biochem Mol Toxicol CrossRef
26. ClC5 Decreases the Sensitivity of Multiple Myeloma Cells to Bortezomib via Promoting Prosurvival Autophagy.
    Huimin Zhang et al, 2018, Oncol Res CrossRef
27. Combination of Second-Generation Proteasome Inhibitor Carfilzomib with Bortezomib in Four Different Breast Cancer Cell Lines
    Ergul Mutlu Altundag et al, 2022, ACAMC CrossRef
28. Clarithromycin overcomes stromal cell-mediated drug resistance against proteasome inhibitors in myeloma cells via autophagy flux blockage leading to high NOXA expression
    Shota Moriya et al, 2023, PLoS ONE CrossRef
29. null
    Masahiro Shinoda, 2024 CrossRef
30. Understanding the Artemia Salina (Brine Shrimp) Test: Pharmacological Significance and Global Impact
    Dionisio A. Olmedo et al, 2024, CCHTS CrossRef